P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis.
P2Y12 抑制劑補充間隙預測接受慢性透析的 Medicare 受益者死亡。
Kidney Int Rep 2024-07-31
Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort.
英國罕見腎病登記處25,880名成人和兒童的描述及橫斷面分析。
Kidney Int Rep 2024-07-31
Insights into the real-world practice of vascular access care pathways in Italy: data from a national survey.
意大利血管通路護理路徑的實務見解:來自全國調查的數據。
J Nephrol 2024-07-30
Screening for tropical and imported infections in migrant kidney transplant candidates from the kidney transplant access consultation.
來自腎臟移植接入諮詢的移民腎臟移植候選人熱帶及進口感染的篩檢。
Nefrologia (Engl Ed) 2024-07-30
The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
強化與標準血壓控制對透析或腎臟移植發生率的遺留效應。
J Am Soc Nephrol 2024-07-30
收縮壓介入試驗(SPRINT)研究了強化與標準收縮壓降低對腎衰竭的長期影響。研究對象為50歲以上、高血壓且心血管風險高的患者,排除了糖尿病、腦中風病史等。參與者隨機分為兩組,目標血壓分別為<120 mm Hg(強化治療)和<140 mm Hg(標準治療)。共9,279名參與者隨訪8.6年,發現101例腎衰竭,強化治療並未顯著增加腎衰竭風險,顯示強化降壓對這群人長期腎衰竭風險無不利影響。
相關文章PubMedDOI
Lysosomal-Associated Protein Transmembrane 5, Tubular Senescence, and Progression of CKD.
溶酶體相關蛋白跨膜 5、腎小管衰老與慢性腎病進展。
J Am Soc Nephrol 2024-07-30
TikTok and pediatric nephrology: content quality assessment of videos related to pediatric kidney disease and kidney transplant.
TikTok 與小兒腎臟科:與小兒腎病及腎臟移植相關影片的內容品質評估。
Pediatr Nephrol 2024-07-30